Free Trial

Theriva Biologics (TOVX) Institutional Ownership

Theriva Biologics logo
$0.38 +0.00 (+0.11%)
Closing price 05/5/2026 04:10 PM Eastern
Extended Trading
$0.36 -0.02 (-4.24%)
As of 05:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Theriva Biologics (NYSEAMERICAN:TOVX)

Current
Institutional Ownership
Percentage
6.17%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$63.74K
Number of
Institutional Sellers
(last 12 months)
0
Get TOVX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theriva Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Theriva Biologics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/9/2026Geode Capital Management LLC212,087$45K0.0%+651.8%0.629%
11/14/2025Two Sigma Investments LP61,837$25K0.0%N/A0.644%
11/15/2024Anson Funds Management LP139,046$192K0.0%N/A6.125%
11/15/2024MSD Partners L.P.27,316$38K0.0%-95.4%1.203%


TOVX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TOVX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Theriva Biologics shares: Anson Funds Management LP ($192K), Geode Capital Management LLC ($45K), and MSD Partners L.P. ($38K), Two Sigma Investments LP ($25K).Learn more on Theriva Biologics' institutional investors.

What percentage of Theriva Biologics' stock is owned by institutional investors?

6.17% of Theriva Biologics' stock is owned by institutional investors. Learn more on TOVX's institutional investor holdings.

Which institutional investors have been buying Theriva Biologics' stock?

The following institutional investors have purchased Theriva Biologics' stock in the last 24 months: Geode Capital Management LLC ($183.88K), Anson Funds Management LP ($139.05K), and Two Sigma Investments LP ($61.84K).

How much institutional buying is happening at Theriva Biologics?

Institutional investors have bought a total of 245,715 shares in the last 24 months. This purchase volume represents approximately $63.74K in transactions.



This page (NYSEAMERICAN:TOVX) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners